Align Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS fell 12.2% and free cash flow grew 85.8%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow ALGN
Align Technology, Inc. (ALGN) Revenue
Align Technology, Inc.'s revenue for fiscal 2025 was $4.0B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $4.1B. Over the past ten years it has ranged from $845.5M (fiscal 2015) to $4.0B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 3 consecutive fiscal years. Align Technology, Inc. ranks 11th of 50 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $4.0B | 0.90% |
| FY2024 | $4.0B | 3.54% |
| FY2023 | $3.9B | 3.42% |
| FY2022 | $3.7B | (5.51%) |
| FY2021 | $4.0B | 59.90% |
| FY2020 | $2.5B | 2.71% |
| FY2019 | $2.4B | 22.39% |
| FY2018 | $2.0B | 33.47% |
| FY2017 | $1.5B | 36.44% |
| FY2016 | $1.1B | 27.72% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $1.1B | 1.55% |
| Mar 2026 | $1.0B | (0.71%) |
| Dec 2025 | $1.0B | 5.21% |
| Sep 2025 | $995.7M | (1.66%) |
| 42 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| BAX Baxter International Inc. compare | $11.5B |
| SOLV Solventum Corporation compare | $8.3B |
| AVTR Avantor, Inc. compare | $6.6B |
| BLCO Bausch + Lomb Corporation compare | $5.3B |
| COO The Cooper Companies, Inc. compare | $4.2B |
| ALGN Align Technology, Inc. | $4.1B |
| ATR AptarGroup, Inc. compare | $3.9B |
| TFX Teleflex Incorporated compare | $2.3B |
| RGEN Repligen Corporation compare | $785.1M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on ALGN
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement